化工社化工社 化学情報印刷レポート · 研究参考用
Clonazepam → 5-(2-chlorophenyl)-2-[bis(morpholino)phosphinyloxy]-7-nitro-3H-1,4-benzodiazepine
関与物質
| 役割 | 名称 | HCID | 仕込み量 |
|---|---|---|---|
| 反応物 | Clonazepam | HCID 2802 | — |
| 反応物 | Sodium hydride | HCID 24758 | — |
| 反応物 | Hydride | HCID 166653 | — |
| 反応物 | Bis(morpholino)phosphinyl chloride | HCID 12506606 | — |
| 反応物 | HCID 178418361 | HCID 178418361 | — |
| 溶媒 | Tetrahydrofuran | HCID 8028 | — |
| 生成物 | 5-(2-chlorophenyl)-2-[bis(morpholino)phosphinyloxy]-7-nitro-3H-1,4-benzodiazepine | HCID 20142991 | — |
反応手順
To a stirred solution of 4.74 g (15 mmoles) of 5-(2-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one in 80 ml of dry tetrahydrofuran at room temperature was added 875 mg of a 50% dispersion of sodium hydride in oil (18 mmoles of hydride). The mixtute was stirred at room temperature for 1 hr until hydrogen evolution stopped. Dimorpholinophosphinic chloride (7.5 g, 30 mmoles) was added and the resulting mixture was stirred at room temperature for 3 hrs. Solids (mixture of product and salt) were collected and partitioned between water and methylene chloride. The methylene chloride layer was dried and evaporated. Crystallization of the residue from methylene chloride ether gave colorless needles, mp 214°-216°.
情報源と証拠
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 特許番号 | US04739049 |
| 出典データセット | uspto-grants-1988_04 |
| ORD ID | ord-455a76d780e64a069b13066b8c593c22 |
| 出典メモ | uspto-grants-1988_04 |